POC Urinalysis Market: Test Type (Sediment, Biochemical,  Flow-Cytometric, Microscopic),  By Application ( UTI, Diabetes,  Liver Disease, Kidney, Pregnancy), End-User (Hospitals, Diagnostic Labs, Others) By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

POC Urinalysis Market size is valued at USD 3.44 billion in 2021 and is expected to reach USD 4.95 billion by 2028, at a CAGR of 6.9% during the forecast period 2022-2028. Latest technologies and increased demand for point-of-care (POC) urine diagnostic tests are projected to drive the urinalysis research market. In the laboratory, there is a strong demand for technically improved urinalysis tools that can offer reliable results in a fast manner. Integrated systems that can do the initial screening and required confirmation testing with microscopy are being used by several mid-and high-volume laboratories to automate their urine testing. Laboratories have had a constant demand for adaptable urinalysis solutions to meet the rising needs of their network. On the other hand, rising applications from advanced markets, as well as the adoption of integrated urinalysis systems, would create several possibilities, resulting in the rise of the point of care (POC) urinalysis market over the projection period. The accessibility of low-quality devices, as well as erroneous findings during crises, are expected to stifle the development of the point-of-care (POC) urinalysis market over the forecast period. The high costs associated with the use of automated analyzers will be the most significant impediment to the market's expansion. Urinalysis is an important aspect of any normal health examination. In addition to disease-specific cardiac biomarkers, chemical substances, and cells/casts, this diagnostic approach may identify disease-specific biomarkers, chemical compounds, and cells/casts in urine samples. Urinalysis is also commonly used for early disease detection and pregnancy and fertility testing. The urinalysis market is predicted to expand due to factors such as rising worldwide incidence of kidney illnesses and urinary tract infections, rising health problems connected with the elderly population, and the development of increasingly improved equipment. POC presents a number of issues, the most significant of which is quality assurance. The conclusion of the test is frequently contrasted with traditional pathology to ensure the accuracy of the test result. Several fast diagnostic tests, especially those used in emergency situations, have failed to deliver correct results. The lack of clarity about the outcome is preventing the widespread use of point-of-care diagnostic equipment. For a complete list of the variables that will drive and challenge the growth of the POC Urinalysis market over the forecast period.

Poc Urinalysis Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

POC Urinalysis Market

Factors such as growing demand for point-of-care testing, enhancement in the global geriatric population, new advancement in technology innovation of urinalysis propels the market growth of POC Urinalysis. Moreover, growth in healthcare expenditure, development of basic medical insurance systems in the near future boost the growth of the POC Urinalysis market. However, factors like lack of laboratory staff, High cost associated with advanced urine analyzers, acceptance of fully automated urine analyzers in growing economies is lower, and stringent regulatory framework may hamper the growth of the POC Urinalysis market. The POC is utilized to distinguish urinary tract diseases (UTI) and different issues of the urinary tract. In patients with intense or constant conditions, for example, kidney ailment, the urinalysis might be requested at interims as a quick technique to help screen organ capacity, status, and reaction to treatment.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Poc Urinalysis Market Segmentation

Test Type
  • Sediment
  • Biochemical
  • Flow-Cytometric
  • Microscopic
By Application
  • UTI
  • Diabetes
  • Liver Disease
  • Kidney
  • Pregnancy
End User
  • Hospitals
  • Diagnostic Labs
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Hoffmann-La Roche Ltd (Switzerland)
  • Dahaner (U.S.)
  • Bio-Rad Laboratories, Inc.  (U.S.)
  • ARKRAY, Inc. (Japan)
  • Siemens AG (U.S.)
  • ACON Laboratories Inc. (U.S.)
  • Sysmex Corporation (Japan)